| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.21B | +5.9% | +28.7% |
| Cost of Revenue | $390.9M | +5.1% | +21.8% |
| Gross Profit | $822.0M | +6.3% | +32.3% |
| R&D Expense | $494.0M | +0.4% | +11.7% |
| SG&A Expense | $107.1M | -10.3% | +0.8% |
| Operating Income | -$329.5M | +3.2% | +9.8% |
| Pre-tax Income | -$287.9M | +3.3% | +11.7% |
| Income Tax | $3.7M | +5838.7% | +90.1% |
| Net Income | -$294.0M | +1.4% | +9.4% |
| EPS (Basic) | -$0.87 | +2.2% | +11.2% |
| EPS (Diluted) | -$0.87 | +2.2% | +11.2% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.94B | +3.2% | -9.6% |
| Accounts Receivable | $938.1M | +45.1% | +57.3% |
| Current Assets | $4.62B | +0.6% | -7.2% |
| Total Assets | $8.23B | +0.4% | +0.3% |
| Current Liabilities | $3.38B | +9.3% | +27.8% |
| Total Liabilities | $6.10B |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $440.8M | — | — |
| Capital Expenditures | $85.6M | — | — |
| Investing Cash Flow | -$107.0M | — | — |
| Financing Cash Flow | -$1.06B | — | — |
| Free Cash Flow | $355.2M | — | — |
| +15.7% |
| Stockholders' Equity | $2.13B | -10.1% | -27.2% |